(Q39021646)

8 September 2017

title

Association of HLA-G polymorphisms with nasopharyngeal carcinoma risk and clinical outcome (English)

1 reference

8 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20969909

8 August 2024

3

Karim Farhat

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20969909

8 August 2024

8

Elham Hassen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20969909

8 August 2024

author name string

Nahla Ghandri

1

1 reference

8 September 2017

Sallouha Gabbouj

2

1 reference

8 September 2017

Noureddine Bouaouina

4

1 reference

8 September 2017

Hamdi Abdelaziz

5

1 reference

8 September 2017

Abdelatif Nouri

6

1 reference

8 September 2017

Lotfi Chouchane

7

1 reference

8 September 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20969909

8 August 2024

publication date

20 October 2010

1 reference

full work available at URL

8 September 2017

https://api.elsevier.com/content/article/PII:S0198885910005203?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2010.10.006

https://api.elsevier.com/content/article/PII:S0198885910005203?httpAccept=text/plain

8 August 2024

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2010.10.006

8 August 2024

1 reference

8 September 2017

volume

72

1 reference

8 September 2017

issue

2

1 reference

8 September 2017

page(s)

150-158

1 reference

The enigmatic epidemiology of nasopharyngeal carcinoma

8 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2010.10.006

Contrasted frequencies of p53 accumulation in the two age groups of North African nasopharyngeal carcinomas

8 August 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2010.10.006

Childhood nasopharyngeal carcinoma: from biology to treatment

8 August 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2010.10.006

Epstein-Barr virus in the pathogenesis of NPC.

8 August 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2010.10.006

HLA associations with nasopharyngeal carcinoma in Southern Chinese: a meta-analysis

8 August 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2010.10.006

The human leukocyte antigen class I genes in nasopharyngeal carcinoma risk.

8 August 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2010.10.006

Associations between HLA class I alleles and the prevalence of nasopharyngeal carcinoma (NPC) among Tunisians.

8 August 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2010.10.006

Haplotype-dependent HLA susceptibility to nasopharyngeal carcinoma in a Southern Chinese population

8 August 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2010.10.006

HLA-E polymorphism in patients with nasopharyngeal carcinoma.

8 August 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2010.10.006

Structure and function of the human MHC class Ib molecules HLA-E, HLA-F and HLA-G

8 August 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2010.10.006

HLA-G and immune evasion in cancer cells

8 August 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2010.10.006

Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis

8 August 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2010.10.006

HLA-G expression in melanoma: a way for tumor cells to escape from immunosurveillance

8 August 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2010.10.006

Upregulation of human leukocyte antigen-G expression and its clinical significance in ductal breast cancer

8 August 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2010.10.006

A functional role of HLA-G expression in human gliomas: an alternative strategy of immune escape

8 August 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2010.10.006

HLA-G protein expression as a potential immune escape mechanism in classical Hodgkin’s lymphoma

8 August 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2010.10.006

Human leukocyte antigen G up-regulation in lung cancer associates with high-grade histology, human leukocyte antigen class I loss and interleukin-10 production

8 August 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2010.10.006

Soluble human leukocyte antigen--G serum level is elevated in melanoma patients and is further increased by interferon-alpha immunotherapy

8 August 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2010.10.006

Soluble HLA-G molecules are increased in lymphoproliferative disorders

8 August 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2010.10.006

8 August 2024

HLA-G and cancer

22

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2010.10.006

Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G

8 August 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2010.10.006

Multiple receptors for HLA-G on human natural killer cells

8 August 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2010.10.006

A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells

8 August 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2010.10.006

HLA-G up-regulates ILT2, ILT3, ILT4, and KIR2DL4 in antigen presenting cells, NK cells, and T cells

8 August 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2010.10.006

Evidence to support the role of HLA-G5 in allograft acceptance through induction of immunosuppressive/ regulatory T cells

8 August 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2010.10.006

HLA-G-mediated inhibition of antigen-specific cytotoxic T lymphocytes

8 August 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2010.10.006

The non-classical MHC molecule HLA-G protects human muscle cells from immune-mediated lysis: implications for myoblast transplantation and gene therapy

8 August 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2010.10.006

Activation of NK cells by an endocytosed receptor for soluble HLA-G.

8 August 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2010.10.006

Cutting edge: soluble HLA-G1 triggers CD95/CD95 ligand-mediated apoptosis in activated CD8+ cells by interacting with CD8

8 August 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2010.10.006

HLA-E-bound peptides influence recognition by inhibitory and triggering CD94/NKG2 receptors: preferential response to an HLA-G-derived nonamer

8 August 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2010.10.006

Increased production of interferon-gamma by tumour infiltrating T lymphocytes in nasopharyngeal carcinoma: indicative of an activated status

8 August 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2010.10.006

A distinct expression of CC chemokines by macrophages in nasopharyngeal carcinoma: implication for the intense tumor infiltration by T lymphocytes and macrophages

8 August 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2010.10.006

Nonclassical HLA-G molecules are classical peptide presenters

8 August 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2010.10.006

Protein expression and peptide binding suggest unique and interacting functional roles for HLA-E, F, and G in maternal-placental immune recognition

8 August 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2010.10.006

Induction of HLA-G-restricted human cytomegalovirus pp65 (UL83)-specific cytotoxic T lymphocytes in HLA-G transgenic mice.

8 August 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2010.10.006

HLA non-A,B,C class I genes: their structure and expression

8 August 2024

39

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2010.10.006

The genetic structure of 3′untranslated region of the HLA-G gene: polymorphisms and haplotypes

8 August 2024

40

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2010.10.006

Human leukocyte antigen-G polymorphism in relation to expression, function, and disease

8 August 2024

41

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2010.10.006

HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation

8 August 2024

42

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2010.10.006

Three new HLA-G alleles and their linkage disequilibria with HLA-A.

8 August 2024

43

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2010.10.006

HLA-G and HLA-E polymorphisms in an indigenous African population. The ZVITAMBO Study Group

8 August 2024

44

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2010.10.006

Maternal human leukocyte antigen-G polymorphism is not associated with pre-eclampsia in a Chinese Han population

8 August 2024

45

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2010.10.006

HLA-G polymorphisms and allele frequencies in Caucasians

8 August 2024

46

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2010.10.006

HLA-G polymorphism and transitional cell carcinoma of the bladder in a Brazilian population

8 August 2024

47

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2010.10.006

HLA-G polymorphisms in women with squamous intraepithelial lesions harboring human papillomavirus

8 August 2024

48

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2010.10.006

HLA-G polymorphisms: neutral evolution or novel function?

8 August 2024

49

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2010.10.006

HLA-G polymorphisms in couples with recurrent spontaneous abortions

8 August 2024

50

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2010.10.006

Variation in the HLA-G Promoter Region Influences Miscarriage Rates

8 August 2024

51

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2010.10.006

HLA-G in human reproduction: aspects of genetics, function and pregnancy complications

8 August 2024

52

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2010.10.006

HLA-G allelic variants are associated with differences in the HLA-G mRNA isoform profile and HLA-G mRNA levels.

8 August 2024

53

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2010.10.006

Association of soluble HLA-G plasma levels with HLA-G alleles

8 August 2024

54

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2010.10.006

The 14 bp deletion polymorphisms in HLA-G gene play an important role in the expression of soluble HLA-G in plasma

8 August 2024

55

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2010.10.006

A new HLA-G allele (HLA-G*0105N) and its distribution in the Spanish population

8 August 2024

56

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2010.10.006

Polymorphism of exon 3 of the HLA-G gene

8 August 2024

57

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2010.10.006

Re-examination of HLA-G polymorphism in African Americans

8 August 2024

58

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2010.10.006

Viewpoint on the functionality of the human leukocyte antigen-G null allele at the fetal-maternal interface

8 August 2024

59

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2010.10.006

The ILT2(LIR1) and CD94/NKG2A NK cell receptors respectively recognize HLA-G1 and HLA-E molecules co-expressed on target cells

8 August 2024

60

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2010.10.006

HLA-G*0105N null allele encodes functional HLA-G isoforms.

8 August 2024

61

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2010.10.006

The alpha1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: is HLA-G the public ligand for natural killer cell inhibitory receptors?

8 August 2024

62

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2010.10.006

Co-dominant expression of the HLA-G gene and various forms of alternatively spliced HLA-G mRNA in human first trimester trophoblast.

8 August 2024

63

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2010.10.006

TAP1 gene polymorphisms and nasopharyngeal carcinoma risk in a Tunisian population.

8 August 2024

64

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2010.10.006

Functional IL-18 promoter gene polymorphisms in Tunisian nasopharyngeal carcinoma patients

8 August 2024

65

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2010.10.006

Interleukin-10 and interferon-gamma gene polymorphisms in patients with nasopharyngeal carcinoma

8 August 2024

66

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2010.10.006

Autoantibodies to tubulin are specifically associated with the young age onset of the nasopharyngeal carcinoma

8 August 2024

67

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2010.10.006

8 August 2024

68

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2010.10.006

Polymorphism in the regulatory region located more than 1.1 kilobases 5' to the start site of transcription, the promoter region, and exon 1 of the HLA-G gene

8 August 2024

69

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2010.10.006

HLA-G unique promoter region: functional implications

8 August 2024

70

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2010.10.006

The miscarriage-associated HLA-G -725G allele influences transcription rates in JEG-3 cells

8 August 2024

71

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2010.10.006

A single base-pair mutation in the 3'-untranslated region of HLA-G mRNA is associated with pre-eclampsia

8 August 2024

72

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2010.10.006

Association between microsatellites within the human MHC and nasopharyngeal carcinoma

8 August 2024

73

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2010.10.006

Nasopharyngeal carcinoma-susceptibility locus is localized to a 132 kb segment containing HLA-A using high-resolution microsatellite mapping

8 August 2024

74

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2010.10.006

Genome-wide association study reveals multiple nasopharyngeal carcinoma-associated loci within the HLA region at chromosome 6p21.3.

8 August 2024

75

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2010.10.006

The HLA-G*0105N null allele induces cell surface expression of HLA-E molecule and promotes CD94/NKG2A-mediated recognition in JAR choriocarcinoma cell line

8 August 2024

76

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2010.10.006

8 August 2024

Identifiers

1 reference

8 September 2017

1 reference